Advanced analytical techniques for testing generic orally inhaled and nasal drug products

Advanced analytical techniques for testing generic orally inhaled and nasal drug products
How to build confidence in the in-vitro data for your generic product.

Our expert, Chris Vernall, Business Development Director, covered a range of technologies during this session:

  • The use and significance of real breathing profiles for emitted dose and impactor testing of OINDPs
  • The use of Morphologically Directed Raman Spectroscopy (MDRS) to determine insitu PSD for powder and suspension formulations.
  • Advanced lung dissolution models
  • How to use the above tools in conjunction with conventional IV-BE tests to avoid costly failures in the clinic
  • What else can we add to move towards true 'IV-IVC'?

Please complete the form below to access the recording.